Skip to main content
. 2018 Sep 5;10(3):147. doi: 10.3390/pharmaceutics10030147

Figure 7.

Figure 7

Plasma concentration–time profiles for oral administration of (a) PFs-SMEDDSNR and (b) PFs-suspension in cycloheximide-pretreated and saline-pretreated rats (mean ± SD, n = 5; ** p < 0.01).